PURPOSE OF REVIEW: The current review covers recent advances in our knowledge of the newest autoantigen neo-epitopes in type 1 diabetes (T1D): hybrid insulin peptides or HIPs. These ligands for autoreactive T cells are formed by peptide fusion, a novel posttranslational modification process that we first reported in 2016. RECENT FINDINGS: Two major HIPs in the nonobese diabetic mouse model, ligands for diabetogenic CD4 T-cell clones, have been incorporated into tetramers and used to track HIP-reactive T cells during progression of disease. HIPs have also been used in strategies for induction of antigen-specific tolerance and show promise for delaying or reversing disease in the nonobese diabetic mouse. Importantly, CD4 T cells reactive to various HIPs have been detected in the islets and peripheral blood mononuclear cell of T1D patients and newly developed human T-cell clones are being employed to gather more data on the phenotype and function of HIP-reactive T cells in patients. SUMMARY: These new hybrid insulin peptide epitopes may provide the basis for establishing autoreactive T cells as biomarkers of disease and as potential tolerogens for treatment of T1D.
PURPOSE OF REVIEW: The current review covers recent advances in our knowledge of the newest autoantigen neo-epitopes in type 1 diabetes (T1D): hybrid insulin peptides or HIPs. These ligands for autoreactive T cells are formed by peptide fusion, a novel posttranslational modification process that we first reported in 2016. RECENT FINDINGS: Two major HIPs in the nonobese diabeticmouse model, ligands for diabetogenic CD4 T-cell clones, have been incorporated into tetramers and used to track HIP-reactive T cells during progression of disease. HIPs have also been used in strategies for induction of antigen-specific tolerance and show promise for delaying or reversing disease in the nonobese diabeticmouse. Importantly, CD4 T cells reactive to various HIPs have been detected in the islets and peripheral blood mononuclear cell of T1D patients and newly developed human T-cell clones are being employed to gather more data on the phenotype and function of HIP-reactive T cells in patients. SUMMARY: These new hybrid insulin peptide epitopes may provide the basis for establishing autoreactive T cells as biomarkers of disease and as potential tolerogens for treatment of T1D.
Authors: Thomas Delong; Timothy A Wiles; Rocky L Baker; Brenda Bradley; Gene Barbour; Richard Reisdorph; Michael Armstrong; Roger L Powell; Nichole Reisdorph; Nitesh Kumar; Colleen M Elso; Megan DeNicola; Rita Bottino; Alvin C Powers; David M Harlan; Sally C Kent; Stuart I Mannering; Kathryn Haskins Journal: Science Date: 2016-02-12 Impact factor: 47.728
Authors: Aaron W Michels; Laurie G Landry; Kristen A McDaniel; Liping Yu; Martha Campbell-Thompson; William W Kwok; Kenneth L Jones; Peter A Gottlieb; John W Kappler; Qizhi Tang; Bart O Roep; Mark A Atkinson; Clayton E Mathews; Maki Nakayama Journal: Diabetes Date: 2016-12-05 Impact factor: 9.461
Authors: Jenny Aurielle B Babon; Megan E DeNicola; David M Blodgett; Inne Crèvecoeur; Thomas S Buttrick; René Maehr; Rita Bottino; Ali Naji; John Kaddis; Wassim Elyaman; Eddie A James; Rachana Haliyur; Marcela Brissova; Lut Overbergh; Chantal Mathieu; Thomas Delong; Kathryn Haskins; Alberto Pugliese; Martha Campbell-Thompson; Clayton Mathews; Mark A Atkinson; Alvin C Powers; David M Harlan; Sally C Kent Journal: Nat Med Date: 2016-10-31 Impact factor: 53.440
Authors: Rocky L Baker; Braxton L Jamison; Timothy A Wiles; Robin S Lindsay; Gene Barbour; Brenda Bradley; Thomas Delong; Rachel S Friedman; Maki Nakayama; Kathryn Haskins Journal: Diabetes Date: 2018-07-05 Impact factor: 9.461
Authors: Timothy A Wiles; Thomas Delong; Rocky L Baker; Brenda Bradley; Gene Barbour; Roger L Powell; Nichole Reisdorph; Kathryn Haskins Journal: J Autoimmun Date: 2016-10-29 Impact factor: 7.094
Authors: Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins Journal: Nat Immunol Date: 2010-02-07 Impact factor: 25.606
Authors: Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth Journal: JAMA Date: 2013-06-19 Impact factor: 56.272
Authors: Angela M Mitchell; Aimon A Alkanani; Kristen A McDaniel; Laura Pyle; Kathleen Waugh; Andrea K Steck; Maki Nakayama; Liping Yu; Peter A Gottlieb; Marian J Rewers; Aaron W Michels Journal: Proc Natl Acad Sci U S A Date: 2021-02-09 Impact factor: 11.205
Authors: Rebecca C Wyatt; William A Hagopian; Bart O Roep; Kashyap A Patel; Brittany Resnick; Rebecca Dobbs; Michelle Hudson; Elisa De Franco; Sian Ellard; Sarah E Flanagan; Andrew T Hattersley; Richard A Oram; Matthew B Johnson Journal: Diabetologia Date: 2022-04-30 Impact factor: 10.460